These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 26793080)

  • 1. Cognitive Training at a Young Age Attenuates Deficits in the zQ175 Mouse Model of HD.
    Curtin PC; Farrar AM; Oakeshott S; Sutphen J; Berger J; Mazzella M; Cox K; He D; Alosio W; Park LC; Howland D; Brunner D
    Front Behav Neurosci; 2015; 9():361. PubMed ID: 26793080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cognitive deficits in transgenic and knock-in HTT mice parallel those in Huntington's disease.
    Farrar AM; Murphy CA; Paterson NE; Oakeshott S; He D; Alosio W; McConnell K; Menalled LB; Ramboz S; Park LC; Howland D; Brunner D
    J Huntingtons Dis; 2014; 3(2):145-58. PubMed ID: 25062858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deficits in a Simple Visual Go/No-go Discrimination Task in Two Mouse Models of Huntington's Disease.
    Oakeshott S; Farrar A; Port R; Cummins-Sutphen J; Berger J; Watson-Johnson J; Ramboz S; Howland D; Brunner D
    PLoS Curr; 2013 Nov; 5():. PubMed ID: 24270512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of Behavioral, Neuropathological, Brain Metabolic and Key Molecular Changes in zQ175 Knock-In Mouse Model of Huntington's Disease.
    Peng Q; Wu B; Jiang M; Jin J; Hou Z; Zheng J; Zhang J; Duan W
    PLoS One; 2016; 11(2):e0148839. PubMed ID: 26859386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative Electroencephalographic Analysis Provides an Early-Stage Indicator of Disease Onset and Progression in the zQ175 Knock-In Mouse Model of Huntington's Disease.
    Fisher SP; Schwartz MD; Wurts-Black S; Thomas AM; Chen TM; Miller MA; Palmerston JB; Kilduff TS; Morairty SR
    Sleep; 2016 Feb; 39(2):379-91. PubMed ID: 26446107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabotropic Glutamate Receptor 5 Antagonism Reduces Pathology and Differentially Improves Symptoms in Male and Female Heterozygous zQ175 Huntington's Mice.
    Li SH; Colson TL; Abd-Elrahman KS; Ferguson SSG
    Front Mol Neurosci; 2022; 15():801757. PubMed ID: 35185467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Compromised Dopaminergic Encoding of Reward Accompanying Suppressed Willingness to Overcome High Effort Costs Is a Prominent Prodromal Characteristic of the Q175 Mouse Model of Huntington's Disease.
    Covey DP; Dantrassy HM; Zlebnik NE; Gildish I; Cheer JF
    J Neurosci; 2016 May; 36(18):4993-5002. PubMed ID: 27147652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The utilisation of operant delayed matching and non-matching to position for probing cognitive flexibility and working memory in mouse models of Huntington's disease.
    Yhnell E; Dunnett SB; Brooks SP
    J Neurosci Methods; 2016 May; 265():72-80. PubMed ID: 26321735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cognitive training modifies disease symptoms in a mouse model of Huntington's disease.
    Yhnell E; Lelos MJ; Dunnett SB; Brooks SP
    Exp Neurol; 2016 Aug; 282():19-26. PubMed ID: 27163546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beneficial effects of miR-132/212 deficiency in the zQ175 mouse model of Huntington's disease.
    Nateghi B; Keraudren R; Boulay G; Bazin M; Goupil C; Canet G; Loiselle A; St-Amour I; Planel E; Soulet D; Hébert SS
    Front Neurosci; 2024; 18():1421680. PubMed ID: 39170678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of discrimination learning in touchscreen and 2-choice swim tank using an allelic series of Huntington's disease mice.
    Glynn D; Skillings EA; Morton AJ
    J Neurosci Methods; 2016 May; 265():56-71. PubMed ID: 26219658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognitive dysfunction precedes neuropathology and motor abnormalities in the YAC128 mouse model of Huntington's disease.
    Van Raamsdonk JM; Pearson J; Slow EJ; Hossain SM; Leavitt BR; Hayden MR
    J Neurosci; 2005 Apr; 25(16):4169-80. PubMed ID: 15843620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. "Brain training" improves cognitive performance and survival in a transgenic mouse model of Huntington's disease.
    Wood NI; Glynn D; Morton AJ
    Neurobiol Dis; 2011 Jun; 42(3):427-37. PubMed ID: 21324361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of Drp1 hyperactivation reduces neuropathology and behavioral deficits in zQ175 knock-in mouse model of Huntington's disease.
    Zhao Y; Sun X; Qi X
    Biochem Biophys Res Commun; 2018 Dec; 507(1-4):319-323. PubMed ID: 30449600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impaired Performance of the Q175 Mouse Model of Huntington's Disease in the Touch Screen Paired Associates Learning Task.
    Piiponniemi TO; Parkkari T; Heikkinen T; Puoliväli J; Park LC; Cachope R; Kopanitsa MV
    Front Behav Neurosci; 2018; 12():226. PubMed ID: 30333735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 'Super-Enrichment' Reveals Dose-Dependent Therapeutic Effects of Environmental Stimulation in a Transgenic Mouse Model of Huntington's Disease.
    Mazarakis NK; Mo C; Renoir T; van Dellen A; Deacon R; Blakemore C; Hannan AJ
    J Huntingtons Dis; 2014; 3(3):299-309. PubMed ID: 25300333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective reduction of striatal mature BDNF without induction of proBDNF in the zQ175 mouse model of Huntington's disease.
    Ma Q; Yang J; Li T; Milner TA; Hempstead BL
    Neurobiol Dis; 2015 Oct; 82():466-477. PubMed ID: 26282324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterisation of progressive motor deficits in whisker movements in R6/2, Q175 and Hdh knock-in mouse models of Huntington's disease.
    Garland H; Wood NI; Skillings EA; Detloff PJ; Morton AJ; Grant RA
    J Neurosci Methods; 2018 Apr; 300():103-111. PubMed ID: 28472678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early cognitive dysfunction in the HD 51 CAG transgenic rat model of Huntington's disease.
    Fink KD; Rossignol J; Crane AT; Davis KK; Bavar AM; Dekorver NW; Lowrance SA; Reilly MP; Sandstrom MI; von Hörsten S; Lescaudron L; Dunbar GL
    Behav Neurosci; 2012 Jun; 126(3):479-87. PubMed ID: 22642889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential effects of voluntary physical exercise on behavioral and brain-derived neurotrophic factor expression deficits in Huntington's disease transgenic mice.
    Pang TYC; Stam NC; Nithianantharajah J; Howard ML; Hannan AJ
    Neuroscience; 2006 Aug; 141(2):569-584. PubMed ID: 16716524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.